Pharmacists Fight Back in Medicare and Medicaid Act
About This Bill
Committee
Latest Action · December 11, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The Pharmacists Fight Back in Medicare and Medicaid Act establishes new federal requirements for pharmacy benefit managers (PBMs) that manage prescription drug coverage under Medicare Part D and Medicaid, effective January 1, 2027. The bill requires PBMs to reimburse pharmacies based on the national average drug acquisition cost plus 4% (or $50, whichever is less), pay dispensing fees matching state Medicaid rates, and pass manufacturer rebates directly to patients at the point of sale to reduce out-of-pocket costs. The legislation prohibits PBMs from steering patients to affiliated pharmacies and mandates annual compliance reporting and expanded pharmacy surveys with publicly available national drug pricing data. The bill establishes significant enforcement mechanisms, including criminal penalties of up to 10 years imprisonment and $1 million fines, plus civil penalties of $1 million per violation, for PBMs that knowingly violate the payment and rebate requirements.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.